May 31, 2011 — BioMarker Strategies has appointed Glenn A. Miller, PhD, as Chairman of its Board of Directors. Dr. Miller previously served on the company's Scientific Advisory Board. Dr. Miller was recently named Vice President and Head of Strategy, Portfolio and Alliances for Personalized Healthcare & Biomarkers at AstraZeneca Pharmaceuticals, LP. Prior to accepting this position, he served for nearly 20 years at Genzyme Genetics, where he was most recently the Vice President and General Manager of a division of Genzyme Genetics, Genzyme Analytical Services. Dr. Miller is a member of the Clinical Sciences Committee of the Personalized Medicine Coalition, has served as a member of the European Federation of Pharmaceutical Industries and Associations Pharmacogenetics ad hoc group and as a member of the Human Genome Organization strategy session on Future Directions of Human Genome Research in Europe. BioMarker Strategies is a tissue-based cancer diagnostics company located at the Johns Hopkins Science + Technology Park in East Baltimore.
| Visionary: The Odyssey of Sir Arthur C. Clarke April 2, 2012 - Visionary offers the first full-life chronicle of the man whose fiction, including his groundbreaking collaboration with Stanley Kubrick on the film "2001," has received all of science fiction’s highest awards, and whose visionary contribution to science has earned him the nickname, "Godfather of the Communication Satellite." Read more at The British Interplanetary Society... |
 |
 |
 |
|
||
 |
|
 |
|
||
|
|
| DBED's Cybersecurity Blog |
| Corridor Inc.’s Strategic Partners |
| CENTER MARYLAND |
| PRESSBOX |
| GREATER BALTIMORE COMMITTEE |
